Gene: SLAMF9
Official Full Name: SLAM family member 9provided by HGNC
Gene Summary: This gene encodes a member of the signaling lymphocytic activation molecule family. The encoded protein is a cell surface molecule that consists of two extracellular immunoglobulin domains, a transmembrane domain and a short cytoplasmic tail that lacks the signal transduction motifs found in other family members. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Apr 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05879 | SLAMF9 Knockout cell line (A549) | Human | SLAMF9 | 1:3~1:4 | Negative | Online Inquiry |
SLAMF9 Gene Knockout Cell Lines are expertly engineered cellular models designed to facilitate the study of the SLAMF9 gene, which encodes a member of the Slam family of proteins involved in immune regulation. By employing CRISPR/Cas9 gene editing technology, these knockout cell lines have effectively led to the loss of SLAMF9 expression, enabling researchers to interrogate the functional roles of this specific gene in various biological contexts.
Key mechanisms facilitated by these cell lines include the investigation of SLAMF9's role in immune cell signaling, lymphocyte activation, and response to pathogenic challenges. Researchers can utilize these models to delineate signaling pathways and cellular interactions that are crucial for both innate and adaptive immunity. This is particularly relevant in the context of autoimmune diseases, infectious diseases, and cancer immunotherapy, where understanding the regulatory mechanisms of immune checkpoints may inform novel therapeutic strategies.
The scientific importance of SLAMF9 Gene Knockout Cell Lines lies in their application for both basic research and translational studies. They serve as versatile tools for pharmacological testing, biomarker discovery, and cellular assays aimed at elucidating immune responses under both healthy and pathological conditions.
Compared to conventional cell lines, which may possess variable expression levels of the SLAMF9 gene, our knockout lines provide a consistent and reproducible model that eliminates confounding variables. This specificity permits focused investigations and accelerates the development of targeted therapies.
For researchers and clinicians alike, these cell lines are indispensable assets in the evolving landscape of immunological research. They offer a unique opportunity to explore novel hypotheses concerning SLAMF9's function, potentially leading to groundbreaking discoveries that could transform therapeutic approaches in immunology and related fields.
Our company prides itself on its extensive expertise in genetic engineering and cell line development, offering high-quality biological products that support innovative research and clinical endeavors. With our commitment to scientific rigor and responsiveness to the needs of the research community, we are dedicated to enhancing your exploration of biological phenomena with our SLAMF9 Gene Knockout Cell Lines.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.